A notable discrepancy in gut microbiota was identified in a study of HCC patients who exhibited a favorable response to PD-1 inhibitors, as compared to those who did not, and two specific bacteria (Actinomyces sp. Here, PDCD1 is linked to hepatocellular carcinoma.